Ghayas Issa

Fadi Haddad: Ghayas Issa presenting the results of AUGMENT-101

Fadi Haddad, Assistant Professor of the Leukemia Department at MD Anderson Cancer Center, Houston, shared a post on X/Twitter:

“Ghayas Issa from MD Anderson Cancer Center presenting the results of AUGMENT-101:

  • N=57 evaluable for efficacy
  • KMT2Ar leukemias
  • Heavily pretreated patients, 46% with >3 prior lines
  • CR/CRh=23%, mOS=8 months
  • No discontinuation due to DS”

Fadi Haddad

Source: Fadi Haddad/X

AUGMENT-101 cancer Fadi Haddad Ghayas Issa MD Anderson Cancer Center OncoDaily Oncology